Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
2004 ◽
Vol 15
(4)
◽
pp. 671-679
◽
P. Schöffski
◽
B. Thate
◽
G. Beutel
◽
O. Bolte
◽
D. Otto
◽
...
1994 ◽
Vol 85
(10)
◽
pp. 1057-1062
◽
Tomohide Tamura
◽
Yasutsuna Sasaki
◽
Kenji Eguchi
◽
Tetsu Shinkai
◽
Yuichiro Ohe
◽
...
2003 ◽
Vol 14
(6)
◽
pp. 913-921
◽
J.P. Braybrooke
◽
E. Boven
◽
N.P. Bates
◽
R. Ruijter
◽
N. Dobbs
◽
...
2013 ◽
Vol 71
(5)
◽
pp. 1247-1254
◽
J. Capdevila
◽
S. Clive
◽
E. Casado
◽
C. Michie
◽
A. Piera
◽
...
2000 ◽
Vol 46
(4)
◽
pp. 319-328
◽
Jeffrey G. Supko
◽
Thomas J. Lynch
◽
Jeffrey W. Clark
◽
Robert Fram
◽
Lee F. Allen
◽
...
2005 ◽
Vol 11
(10)
◽
pp. 3806-3813
◽
Maja J.A. de Jonge
◽
Ate van der Gaast
◽
André S.T. Planting
◽
Leny van Doorn
◽
Aletta Lems
◽
...
2005 ◽
Vol 16
(10)
◽
pp. 1695-1701
◽
A.H.G. Hansma
◽
H.J. Broxterman
◽
I. van der Horst
◽
Y. Yuana
◽
E. Boven
◽
...
1986 ◽
Vol 18
(1)
◽
pp. 33-38
◽
N. Simon Tchekmedyian
◽
Merrill J. Egorin
◽
Brian E. Cohen
◽
Richard S. Kaplan
◽
Elizabeth Poplin
◽
...
SophieD. Foss�
◽
Asbj�rn Flokkmann
◽
Mona Heier
◽
Magne Aas
◽
Brit Moe
◽
...
2008 ◽
Vol 14
(10)
◽
pp. 3105-3112
◽
Miguel A. Izquierdo
◽
Angela Bowman
◽
Margarita García
◽
Duncan Jodrell
◽
Marisa Martinez
◽
...
Close
Export Citation Format
Close
Share Document
Close